| 11.17.21 | Novartis bags option to buy eye delivery tech; AbbVie extends University of Chicago cancer pact

Laden...

3 jaren geleden

Html
Tekst

Webinar: The Future of Pharmaceutical Glass

Tuesday, November 30 | 11am ET/ 8 am PT

Traditional pharmaceutical glass containers create processing bottlenecks that limit the efficiency of fill-finish operations. Corning Pharmaceutical Technologies has responded to these limitations by developing the next generation of primary glass packaging. This webinar will introduce Corning’s coated vial technology that provides multiple benefits to pharma and CMOs. Register Now.

Today's Rundown

Novartis sees future beyond eye drops, bagging option to buy developer of drug delivery tech AbbVie re-ups University of Chicago cancer pact, extending alliance out to 2025 after drug delivery progress MyLife, with COVID-19 in its sights, raises cash to advance vaccine patch delivery tech Inovio clears up queries about delivery of COVID-19 vaccine, prompting FDA to lift clinical hold GlaxoSmithKline, Vir target emergency authorization for intramuscular COVID-19 antibody drug with new trial win 2021's Fiercest Women in Life Sciences

Featured Story

Novartis sees future beyond eye drops, bagging option to buy developer of drug delivery tech

By Nick Paul Taylor

Novartis has identified drug delivery as an enabler of its push for the front-of-the-eye market. Having signaled its interest in the space with a $3.4 billion deal, Novartis has followed up with an investment that gives it an option to buy Kedalion Therapeutics for its topical ocular delivery device.

Webinar: A Systems Model of Gene Therapy for Sickle Cell Disease

Tuesday, November 30 | 2pm ET / 11am PT

Stem cell gene therapy is an emerging experimental therapy for SCD with the potential for lifelong cure but it is an expensive multi-step treatment regimen. This webinar is ideal for scientists and decision makers in drug R&D who want to leverage systems pharmacology for drug discovery and development. Register Now.

AbbVie re-ups University of Chicago cancer pact, extending alliance out to 2025 after drug delivery progress

By Nick Paul Taylor

AbbVie has re-upped its collaboration with the University of Chicago, extending the relationship out to 2025 after spending the past five years working on activities including the development of novel drug delivery approaches.

MyLife, with COVID-19 in its sights, raises cash to advance vaccine patch delivery tech

By Nick Paul Taylor

Are skin patches the future of vaccine delivery? That is the hope of investors in MyLife Technologies, who have provided cash to support production of ceramic vaccine patches for clinical studies.

Inovio clears up queries about delivery of COVID-19 vaccine, prompting FDA to lift clinical hold

By Nick Paul Taylor

Inovio has worked through the FDA’s questions about its COVID-19 vaccine delivery device, leading the agency to lift a partial clinical hold and clear the biotech to start enrolling subjects in the U.S.

GlaxoSmithKline, Vir target emergency authorization for intramuscular COVID-19 antibody drug with new trial win

By Angus Liu

GlaxoSmithKline and Vir Biotechnology’s COVID-19 antibody drug sotrovimab already bears an FDA emergency use authorization as an infusion. Now, the pair hopes to win the same status for an intramuscular formulation.

2021's Fiercest Women in Life Sciences

By Annalee Armstrong

“It took a village to make me.” These words spoken by WeiQing Zhou, who is the cofounder of two biotechs, could apply to almost any of the women on the 2021 Fiercest Women in Life Sciences list.

Webinar: Oral solid dose formulations: Integrating patient centricity into development and lifecycle strategies

Wednesday, December 1, 2021 | 11am ET/ 8am PT

Meeting the increasing demand for patient centricity in drug design is key to your molecule’s success. Learn how to implement development and lifecycle management strategies. Register Now.